Why Making Dramatic Moves: Petroleo Brasileiro Petrobras (NYSE:PBR), AVEO Pharmaceuticals (NASDAQ:AVEO), The Procter & Gamble Company (NYSE:PG), Akorn (NASDAQ:AKRX), Newpark Resources (NYSE:NR)

On Monday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) closed at $9.78. Company’s sales growth for last 5 years was 3.60% and EPS growth for next 5 years is recorded as 0.35%. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) underwent a board shake-up late on 29 April, that went mostly as expected, with its interim chairman being replaced by the chief executive of the country’s top mining company.

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) in last trading activity moved up 5.96% to close at $1.60. Company weekly performance is -12.09% while its quarterly performance stands at 58.42%. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) is -26.27% away from its 52 week high. On 29 April, AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) declared the appointment of Keith S. Ehrlich to the position of chief financial officer. In this role, Mr. Ehrlich will be responsible for the company’s financial and administrative strategy and administration, and will serve on the executive leadership team which governs corporate strategy. He will report to Michael Bailey, AVEO’s president and chief executive officer.

On last trading day The Procter & Gamble Company (NYSE:PG) moved up 0.07% to close at $80.35. Its volatility for the week is 0.92% while volatility for the month is 1.10%. PG’s sales growth for past 5 years was 1.60% and its EPS growth for past 5 years was 2.80%. The Procter & Gamble Company (NYSE:PG) monthly performance is -1.74%. A public hearing on The Procter & Gamble Company (NYSE:PG)’s plans to construct its $500 million manufacturing plant in Berkeley County takes place on 27 April.

Akorn, Inc. (NASDAQ:AKRX) has 3.30% insider ownership while its institutional ownership stands at 81.10%. In last trading activity company’s stock closed at $42.21. Akorn, Inc. (NASDAQ:AKRX) announced on 24 April, that it will have to restate financials from 2014 due to accounting errors. Akorn warned that their financial reports for 2014, filed by KMPG, should not be relied upon. Though the pharmaceutical company affirmed its 2015 earnings per share guidance, the stock fell by more than 20% on Monday following the announcement.

On last trading day Newpark Resources Inc. (NYSE:NR) remains unchanged to close at $10.00. Its volatility for the week is 4.84% while volatility for the month is 3.90%. NR’s sales growth for past 5 years was 17.90% and its EPS growth for past 5 years was 41.40%. Newpark Resources Inc. (NYSE:NR) monthly performance is 7.64%. Newpark Resources (NYSE:NR) was downgraded by Zacks
from a “hold” rating to a “sell” rating in a note issued to investors on Friday.

Leave a Reply

Your email address will not be published. Required fields are marked *